In 1997, a survey showed that patients would have been enthusiastic on the idea that easily administered formulations would substantially expand the use of glucagon to prevent or to treat hypos, but a survey showed that 75% adult patients with diabetes did not carry a glucagon emergency kit [9]. The gene discussed is GCG; the disease is diabetes mellitus.